Literature DB >> 19818802

The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe?

Marina de Bernard1, Mario M D'Elios.   

Abstract

The Helicobacter pylori HP-NAP is a dodecameric protein with a three-dimensional structure similar to that of bacterioferritins. Originally defined as neutrophil-activating protein, because of its ability to stimulate neutrophils to produce oxygen radicals, HP-NAP is now considered a crucial factor in driving the Th1 inflammation in H. pylori infection. This review summarizes recent studies that have provided a deeper understanding of the pro-inflammatory and immune modulatory properties of HP-NAP. We first examine the role of this protein in the H. pylori-associated disease, and then we discuss recent findings that support the possibility for HP-NAP to become a new tool for therapeutic strategies aimed at redirecting Th2 into Th1 responses, for example in atopy, vaccinology and cancer immunotherapy.
Copyright © 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818802     DOI: 10.1016/j.toxicon.2009.09.020

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  20 in total

1.  Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model.

Authors:  Gaia Codolo; Fabio Munari; Matteo Fassan; Marina de Bernard
Journal:  J Vis Exp       Date:  2015-05-29       Impact factor: 1.355

2.  One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode.

Authors:  Ting-Yu Kuo; Zhi-Wei Hong; Chung-Che Tsai; Yu-Chi Yang; Hua-Wen Fu
Journal:  J Vis Exp       Date:  2016-06-18       Impact factor: 1.355

Review 3.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.

Authors:  Ianko D Iankov; Cory Allen; Mark J Federspiel; Rae M Myers; Kah Whye Peng; James N Ingle; Stephen J Russell; Evanthia Galanis
Journal:  Mol Ther       Date:  2012-02-14       Impact factor: 11.454

Review 5.  HP-NAP of Helicobacter pylori: The Power of the Immunomodulation.

Authors:  Gaia Codolo; Sara Coletta; Mario Milco D'Elios; Marina de Bernard
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

Review 6.  Chinese Helicobacter pylori vaccine: Solution for an old challenge?

Authors:  Amin Talebi Bezmin Abadi; Yeong Yeh Lee
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

Review 7.  Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications.

Authors:  Hua-Wen Fu
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

8.  Gene expression profiling in gastric mucosa from Helicobacter pylori-infected and uninfected patients undergoing chronic superficial gastritis.

Authors:  Ze-Min Yang; Wei-Wen Chen; Ying-Fang Wang
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

9.  Isolation Method and Characterization of Outer Membranes Vesicles of Helicobacter pylori Grown in a Chemically Defined Medium.

Authors:  Joana Melo; Vanessa Pinto; Tânia Fernandes; Ana R Malheiro; Hugo Osório; Ceu Figueiredo; Marina Leite
Journal:  Front Microbiol       Date:  2021-06-02       Impact factor: 5.640

10.  Crosstalk between Helicobacter pylori and gastric epithelial cells is impaired by docosahexaenoic acid.

Authors:  Marta Correia; Valérie Michel; Hugo Osório; Meriem El Ghachi; Mathilde Bonis; Ivo G Boneca; Hilde De Reuse; António A Matos; Pascal Lenormand; Raquel Seruca; Ceu Figueiredo; Jose Carlos Machado; Eliette Touati
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.